2018 EAU prostate cancer guidelines

SelectMDx has been included in the 2018 EAU guidelines.


2018 EAU guidelines


The SelectMDx test is based on mRNA biomarker isolation from urine. The presence of HOXC6 and DLX1 mRNA levels is assessed to provide an estimate of the risk of both presence of PCa on biopsy as well as presence of high-risk cancer.

The guidelines committee states that ‘Based of the available evidence, some biomarkers could help in discriminating between aggressive and non-aggressive tumours with an additional value compared to the prognostic parameters currently used by clinicians’.


Read the guidelines

Stay informed about new biomarker updates

Fields wrapper

Get a free test

Get started
* Required fields